Ciclopirox

This classification denotes an antifungal agent with the molecular formula C12H17NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 19W019ZDRJ, chemically known as 2(1h)-pyridone, 6-cyclohexyl-1-hydroxy-4-methyl- but generally known as ciclopirox, which bears US NIH Compound Identifier 2749. European Medicines Agency schedules Ciclopirox in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06245MIG. The term CICLOPIROX is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules ciclopirox in its Anatomical Therapeutic Chemical (ATC) Classification. CICLOPIROX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ciclopirox under HS 29337900 and SITC 51561. As of Q4 2014, CICLOPIROX remains the US FDA Preferred Term for this commodity. Ciclopirox bears US NLM identifiers UMLS ID C0055711 and NCI Concept Code C61677. SMILES: CC1=CC(=O)N(C(=C1)C2CCCCC2)O.